Cantor Fitzgerald Not Worried About Amazon's (AMZN) Entry Into Prescription Market
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Guggenheim Remains Bullish on Amazon (AMZN) Following PillPack Acquisition
July 2, 2018 7:37 AM EDTGuggenheim reiterated a Buy rating and $1850.00 price target on Amazon.com (NASDAQ: AMZN) following the company's recent acquisition of PillPack. This drove a 5-10% correction in drug retail shares on the assumption that this would place incremental pressure on pricing and profitability.
Analyst John... More
